Synergistic Modulation of ATP-Sensitive K + Currents by Protein Kinase C and Adenosine
- 1 March 1996
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 78 (3) , 443-454
- https://doi.org/10.1161/01.res.78.3.443
Abstract
Ischemic preconditioning has been shown to involve the activation of adenosine receptors, protein kinase C (PKC), and ATP-sensitive K+ (KATP) channels. We investigated the effects of PKC activation and adenosine on KATP current (IK,ATP) and action potentials in isolated rabbit ventricular myocytes. Responses to pinacidil (100 to 400 μmol/L), an opener of KATP channels, were markedly increased by preexposure to the PKC activator phorbol 12-myristate 13-acetate (PMA, 100 nmol/L). IK,ATP measured at 0 mV was increased by PMA pretreatment from 0.55±0.32 to 3.25±0.47 nA (n=6, P<.01). We next determined whether PKC activation abbreviates the time required to turn on IK,ATP during metabolic inhibition (MI). In control cells in which MI was induced by 2 mmol/L cyanide and 0 glucose, IK,ATP developed after an average of 15.1±2.4 minutes (n=8). Ten-minute pretreatment with PMA alone (PMA+MI) did not significantly alter this latency (11.9±2.0 minutes, n=8). Since adenosine receptor activation has been shown to play an important role in the preconditioning response, two groups of myocytes were studied with adenosine (10 μmol/L) included during MI. Without PMA, adenosine alone (MI+Ado) did not affect the latency to develop IK,ATP (12.3±1.5 minutes, n=8). However, if cells were pretreated with PMA and then subjected to MI in the presence of adenosine (PMA+MI+Ado), the latency was greatly shortened to 5.5±1.6 minutes (n=8; P<.02 versus MI, PMA+MI, and MI+Ado groups). This effect could not be reproduced by an inactive phorbol but was completely abolished by the adenosine receptor antagonist 8-(p-sulfophenyl)-theophylline. The opening of KATP channels may be cardioprotective because of the abbreviation of action potential duration (APD) during ischemia. Therefore, we tested whether PKC activation could modify the time course of APD shortening during MI. Consistent with the ionic current measurements, PMA pretreatment significantly accelerated APD shortening, but only when adenosine (10 μmol/L) was included during MI. The effects were not attributable to accelerated ATP consumption: PMA pretreatment did not alter the time required to induce rigor during MI, whether or not adenosine was included. Our results indicate that PKC activation increases the IK,ATP induced by pinacidil or by MI. The latter effect requires concomitant adenosine receptor activation. The synergistic modulation of IK,ATP by PKC and adenosine provides an explicit basis for current paradigms of ischemic preconditioning.Keywords
This publication has 50 references indexed in Scilit:
- Regulation of adenosine triphosphate-sensitive potassium channels from rabbit ventricular myocytes by protein kinase C and type 2A protein phosphataseBiochemistry, 1995
- Adenosine receptor specificity in preconditioning of isolated rabbit cardiomyocytes: evidence of A3 receptor involvementCardiovascular Research, 1994
- Evidence that Translocation of Protein Kinase C is a Key Event During Ischemic Preconditioning of Rabbit MyocardiumJournal of Molecular and Cellular Cardiology, 1994
- Protection of the heart by ischaemic preconditioning: mechanisms and possibilities for pharmacological exploitationTrends in Pharmacological Sciences, 1994
- An explanation for the reported observation that ATP dependent potassium channel openers mimic preconditioningCardiovascular Research, 1993
- The Pharmacology of ATP-Sensitive Potassium ChannelsAnnual Review of Pharmacology and Toxicology, 1993
- Protection from ischaemic-reperfusion injury with adenosine pretreatment is reversed by inhibition of ATP sensitive potassium channelsCardiovascular Research, 1993
- Limitation of infarct size in the rabbit by ischaemic preconditioning is reversible with glibenclamideCardiovascular Research, 1993
- Blockade of ischaemic preconditioning in dogs by the novel ATP dependent potassium channel antagonist sodium 5-hydroxydecanoateCardiovascular Research, 1992
- An in vitro model of myocardial ischemia utilizing isolated adult rat myocytesJournal of Molecular and Cellular Cardiology, 1990